To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

antibody
New Evidence Shows COVID-19 Was in US Weeks Before Thought
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Abby Olena | Jun 17, 2021
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
What Pseudoviruses Bring to the Study of SARS-CoV-2
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena | Feb 16, 2021
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
COVID-19 May Have Arrived in US in December: Study
COVID-19 May Have Arrived in US in December: Study
Max Kozlov | Dec 2, 2020
SARS-CoV-2 antibodies detected in blood donor samples indicate infections could have occurred in the US more than a month before the first confirmed case, but some experts remain skeptical.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Vast Majority in US Remain Susceptible to COVID-19: Study
Vast Majority in US Remain Susceptible to COVID-19: Study
Max Kozlov | Sep 28, 2020
Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Zika Infection Increases Risk of Severe Dengue Fever
Zika Infection Increases Risk of Severe Dengue Fever
Ruth Williams | Aug 27, 2020
A study of Nicaraguan children links prior Zika virus infection with aggravated dengue fever symptoms.
Some COVID-19 Patients Lack Key Structures for Antibody Creation
Some COVID-19 Patients Lack Key Structures for Antibody Creation
Katarina Zimmer | Aug 25, 2020
An absence of germinal centers—which arise during infections to produce long-lived antibody-generating cells—might explain rapidly waning antibody levels in the disease.
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
Amanda Heidt | Aug 24, 2020
White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Shawna Williams | Aug 14, 2020
Researchers say the popularity of convalescent plasma makes it more difficult to gather high-quality data on its efficacy.
For Mates to Fuse Bodies, Some Anglerfish Have Lost Immune Genes
For Mates to Fuse Bodies, Some Anglerfish Have Lost Immune Genes
Katarina Zimmer | Jul 30, 2020
In most vertebrates, the absence of adaptive immunity would be catastrophic, but in some deep-sea angler fish species, it enables their “wild” and “wacky” mating habits.